Pilulka Lékárny a.s. has completed an IPO on the START Market of the Prague Stock Exchange
Pilulka Lékárny a.s. has completed an IPO on the START Market of the Prague Stock Exchange consisting of a capital increase and the disposal of secondary shares.
Founded in 2013, Pilulka is one of the most significant players consolidating the online and offline pharmacy markets in Central Europe. Pilulka is the number one pharmacy e-shop in the home delivery segment in the Czech Republic and Slovakia, and among the top three retail pharmacy chains in the Czech Republic, with 152 branded pharmacies. The company entered the Romanian online pharmacy market in 2018 and plans to expand into Hungary in 2021. Pilulka is a data-driven market disruptor leveraging its tailor-made and easily scalable IT solutions. Furthermore, the company is backed by a strong management team led by Czech e-commerce tycoons Petr and Martin Kasa, who founded the company.
Oaklins’ team in the Czech Republic acted as the IPO manager in this transaction. The team succeeded in attracting orders from high-net-worth individuals and experienced investors, and also from a broad range of retail and institutional investors.
Talk to the deal team
Related deals
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreOBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn more